EULAR/LinkedIn
Dec 18, 2025, 13:16
New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR
EULAR – European Alliance of Associations for Rheumatology shared a post on LinkedIn:
“NEWS ALERT!
EULAR has developed a new score that quantifies the level of disease activity in people with antiphospholipid syndrome (APS). A key step forward that promises to advance research and improve symptom tracking, both in clinical trials and everyday practice.
Read the full EULAR Press Release here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Dec 18, 2025, 13:55Insights from Cendrine Siraudin on Fertility Support – Destination Santé
-
Dec 18, 2025, 13:34Alberto Sifuentes Giraldo: Key Insights on Antiphospholipid Syndrome From Recent Study
-
Dec 18, 2025, 13:28New Webinar on Managing Bipolar Disorder in Perinatal Patients – The Periscope Project Perinatal Specialty Consult Psychiatry
-
Dec 18, 2025, 13:08IVF/ICSI Outcomes in POSEIDON Low-Prognosis Patients – Fertility and Sterility
-
Dec 18, 2025, 12:53Next Meeting of Society of Reproductive Medicine Announced – Agence Dixit Presse
-
Dec 18, 2025, 12:50Ramchandra Dige: IVF Services Market Size Grows From USD 28.55 Billion to USD 66.30 Billion
-
Dec 18, 2025, 12:38Arif Pandit: From Maternal-Fetal Interface to Assisted Reproductive Technologies
-
Dec 18, 2025, 12:28Exploring Immune System Malfunctions in Miscarriage – Fertility Plus
-
Dec 17, 2025, 17:09Wajeeha Shahid: Unraveling Genetic Factors in Male Infertility